Clinical Study of the treatment of pimples by Unani ointment.

A Prospective, Randomized, Parallel Group, Open Label, Active Controlled Clinical Study to Evaluate the Efficacy and Safety of a Polyherbal Unani Formulation in the Management of ButhÅ«r Labaniyya (Acne Vulgaris)

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/08/036095

Enrollment

Registered

2021-08-31

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L700- Acne vulgaris

Interventions

Intervention1: Polyherbal Unani Formulation (Local): Patients will be advised to apply Unani formulation (in the form of paste) locally on the affected site once daily. Control Intervention1: Benzoyl

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients of any sex in the age group between 14 and 40 Years 2. Clinically stable patients 3. Patients having the following symptoms of ButhÅ«r Labaniyya: Comedones, Papules, Pustules, Nodules, Itching, Erythema.

Exclusion criteria

Exclusion criteria: 1. Patients aged 40 years 2. Pregnant or Lactating Women 3. Mentally retarded person 4. Patients on corticosteroid or anticonvulsant therapy or taking oral contraceptives 5. Patients suffering from other concomitant diseases like acne rosacea, acne fulminance, acne necrotica, psoriasis, eczema, etc. 6. Significant Pulmonary/Cardiovascular/Hepato-renal dysfunction 7. Patient not willing to attend treatment schedule regularly

Design outcomes

Primary

Measure	Time frame
The safety to treatment will be assessed by following: 1. Adverse effects 2. Laboratory Investigations (haemogram, LFTs, KFTs).Timepoint: 1. At 2nd wk, 4th wk and 6th wk. 2. At baseline and 6th wk.	—

Secondary

Measure	Time frame
The response to treatment will be assessed by using the following parameters : 1. Global Acne Grading System (GAGS) 2. Photographic Standards for Acne Grading (PSAG) 3.To compare the improvement in quality of life in patients with Acne Vulgaris assessed by PGA on VAS. 4.Clinical recovery Timepoint: 1. At Fortnightly 2. At baseline and 6th wk. 3. At baseline and 6th wk 4. At Fortnightly	—

Countries

India

Contacts

Public ContactProf Qamar Uddin

National Research Institute of Unani Medicine for skin disorders

ccrumhqrsnd58@gmail.com8700027178

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026